Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Beesley

Showing results (131-140 of 139) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 139 results.
Intensive Care Medicine|June 6, 2019
Key mechanisms by which post-ICU activities can improve in-ICU care: results of the international THRIVE collaborativesKimberley J Haines, Carla M Sevin, Elizabeth Hibbert, et al.
The New England Journal of Medicine|March 25, 2026
Probable Japanese Encephalitis Virus Transmission through Organ TransplantationHannah Padda, Susan Hills, Charles Y Chiu, et al.
British Journal of Cancer|January 26, 2008
Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysisC L Pearce, A H Wu, S A Gayther, et al.
Critical Care Medicine|November 14, 2018
Models of Peer Support to Remediate Post-Intensive Care Syndrome: A Report Developed by the Society of Critical Care Medicine Thrive International Peer Support CollaborativeJoanne McPeake, Eliotte L Hirshberg, Leeann M Christie, et al.
British Journal of Cancer|January 8, 2009
Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association ConsortiumC L Pearce, A M Near, D J Van Den Berg, et al.
British Journal of Cancer|August 27, 2009
The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriersO M Sinilnikova, A C Antoniou, J Simard, et al.
British Journal of Cancer|March 24, 2011
Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2A Osorio, R L Milne, R Alonso, et al.
British Journal of Cancer|June 7, 2012
Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter studyA Jakubowska, D Rozkrut, A Antoniou, et al.
British Journal of Cancer|November 19, 2009
Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)A Osorio, R L Milne, G Pita, et al.
Pageof 14

Showing results (131-140 of 139) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 139 results.
Intensive Care Medicine|June 6, 2019
Key mechanisms by which post-ICU activities can improve in-ICU care: results of the international THRIVE collaborativesKimberley J Haines, Carla M Sevin, Elizabeth Hibbert, et al.
The New England Journal of Medicine|March 25, 2026
Probable Japanese Encephalitis Virus Transmission through Organ TransplantationHannah Padda, Susan Hills, Charles Y Chiu, et al.
British Journal of Cancer|January 26, 2008
Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysisC L Pearce, A H Wu, S A Gayther, et al.
Critical Care Medicine|November 14, 2018
Models of Peer Support to Remediate Post-Intensive Care Syndrome: A Report Developed by the Society of Critical Care Medicine Thrive International Peer Support CollaborativeJoanne McPeake, Eliotte L Hirshberg, Leeann M Christie, et al.
British Journal of Cancer|January 8, 2009
Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association ConsortiumC L Pearce, A M Near, D J Van Den Berg, et al.
British Journal of Cancer|August 27, 2009
The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriersO M Sinilnikova, A C Antoniou, J Simard, et al.
British Journal of Cancer|March 24, 2011
Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2A Osorio, R L Milne, R Alonso, et al.
British Journal of Cancer|June 7, 2012
Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter studyA Jakubowska, D Rozkrut, A Antoniou, et al.
British Journal of Cancer|November 19, 2009
Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)A Osorio, R L Milne, G Pita, et al.
Pageof 14